Authors:
VALERO V
HOFF P
SINGLETARY ES
BUZDAR AU
BOOSER DJ
ASMAR L
MCNEESE M
HORTOBAGYI GN
Citation: V. Valero et al., TAMOXIFEN AS PRIMARY THERAPY IN COMBINED-MODALITY TREATMENT OF ELDERLY PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 78-78
Authors:
VALERO V
BUZDAR AU
ASMAR L
THERIAULT RL
BOOSER DJ
MCNEESE M
SINGLETARY SE
HORTOBAGYI GN
Citation: V. Valero et al., ADJUVANT ANTHRACYCLINE-CONTAINING THERAPY IN WOMEN GREATER-THAN-OR-EQUAL-TO-65 YEARS WITH BREAST-CANCER - THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE, Annals of oncology, 9, 1998, pp. 144-144
Authors:
VALERO V
JONES SE
VONHOFF DD
BOOSER DJ
MENNEL RG
RAVDIN PM
HOLMES FA
RAHMAN Z
SCHOTTSTAEDT MW
ERBAN JK
ESPARZAGUERRA L
EARHART RH
HORTOBAGYI GN
BURRIS HA
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3362-3368
Authors:
HOLMES FA
MADDEN T
NEWMAN RA
VALERO V
THERIAULT RL
FRASCHINI G
WALTERS RS
BOOSER DJ
BUZDAR AU
WILLEY J
HORTOBAGYI GN
Citation: Fa. Holmes et al., SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2713-2721
Authors:
WALTERS RS
THERIAULT RL
BOOSER DJ
ESPARZA L
HORTOBAGYI GN
Citation: Rs. Walters et al., PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON (RIFN-ALPHA) AND CONTINUOUS-INFUSION 5-FLUOROURACIL IN METASTATIC BREAST-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 18(3), 1995, pp. 185-187
Authors:
BUZDAR AU
HORTOBAGYI GN
FRYE D
HO D
BOOSER DJ
VALERO V
HOLMES FA
BIRMINGHAM BK
BUI K
YEH C
PLOURDE PV
Citation: Au. Buzdar et al., BIOEQUIVALENCE OF 20-MG ONCE-DAILY TAMOXIFEN RELATIVE TO 10-MG TWICE-DAILY TAMOXIFEN REGIMENS FOR BREAST-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 50-54